![Kirsten Doerfert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Kirsten Doerfert
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Medical Specialties | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kirsten Doerfert
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ENTEGRIS, INC. | Industrial Machinery | Chairman | |
Zavante Therapeutics, Inc.
![]() Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Alpha-9 Oncology, Inc.
![]() Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Inflazome Ltd.
![]() Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
MOLECULAR TEMPLATES, INC. | Biotechnology | Director/Board Member | |
TRICIDA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Helomics Corp.
![]() Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Director/Board Member | |
RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Civitas Therapeutics, Inc.
![]() Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
Longitude Capital Management Co LLC
![]() Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | Investment Managers | Founder | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
FirstMark Capital LLC
![]() FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
University of Wisconsin | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 23 |
Kanada | 2 |
Irland | 2 |
Sektoral
Health Technology | 10 |
Finance | 6 |
Consumer Services | 4 |
Producer Manufacturing | 3 |
Commercial Services | 3 |
Operativ
Director/Board Member | 16 |
Independent Dir/Board Member | 4 |
Chairman | 2 |
Doctorate Degree | 2 |
Private Equity Investor | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Hirsch | 20 |
James E. Dauwalter | 5 |
Jess R. Carsello | 2 |
- Börse
- Insiders
- Kirsten Doerfert
- Unternehmensverbindungen